You are here: Industry Insights > Lonza

News List

Lonza to Exit Pharma Softgels and Liquid-Filled Hard Capsules contractpharma
January 20, 2021
Lonza and NextPharma have formed an agreement for the potential sale of Lonza's Ploermel, France and Edinburgh, UK sites, subject to relevant conditions and regulatory approvals.
Cytiva delivers modular biologics factory to Lonza prnasia
January 14, 2021
Cytiva, a global life sciences leader, has successfully completed another KUBio installation, this time to global healthcare solutions provider Lonza, in Guangzhou Biopark, China.
Capricor, Lonza Enter CAP-1002 Development Agreement contractpharma
January 13, 2021
Lonza will perform process development activities for late-clinical and commercial-scale GMP manufacturing of CAP-1002.
Lonza Expands Conjugation Facility in Visp contractpharma
December 22, 2020
Two additional manufacturing suites will provide development and manufacturing capacity for preclinical to commercial supply.
MODA-EM Paperless Solution to be Implemented at UK Vaccines Manufacturing Centre americanpharmaceuticalreview
December 21, 2020
Lonza and the Vaccines Manufacturing and Innovation Centre (VMIC) announced a project to implement the MODA-EM™ Solution to automate quality control (QC) in the new facility.
Aurinia and Lonza Expand Manufacturing Partnership contractpharma
December 17, 2020
Aurinia Pharmaceuticals and Lonza have expanded their exclusive manufacturing relationship. The parties entered into a collaborative agreement to build a dedicated manufacturing capacity within Lonza’s existing small molecule API facility in Visp ...
UK’s VMIC to Implement Lonza’s MODA-EM contractpharma
December 09, 2020
The Vaccines Manufacturing and Innovation Centre in Oxfordshire (VMIC), UK has selected Lonza’s MODA-EM Solution to digitize its Microbiology Quality Control operations.
Lonza Enters Long-term Bioconjugation Collaboration contractpharma
December 03, 2020
Will construct two new customer-dedicated conjugation suites for the commercialization of antibody-drug conjugates at its Visp site.
Lonza Congratulates Moderna on Interim Phase 3 Clinical Trial Data americanpharmaceuticalreview
November 26, 2020
Lonza has released the following statement congratulating Moderna on its recent clinical trial:“We congratulate Moderna on this important milestone, which represents a significant scientific achievement and serves as a testament to Moderna’s commitment ..
Lonza and Be The Match BioTherapies Enter CGT Partnership contractpharma
November 25, 2020
Be The Match BioTherapies, an organization offering solutions for companies developing and commercializing cell and gene therapies (CGT), and Lonza have entered a partnership to integrate industry-leading solutions in CGT.

Previous page 1 2 3 4 5 6 7 8 9 10 11 12 Next page